Fridlender et al. [118] demonstrated that TGF-β production in the CRC TME polarizes TANs from an immunostimulatory “N1” phenotype to a pro-tumorigenic “N2” phenotype. The gene discussed is TGFB1; the disease is colorectal carcinoma.